瘢痕核心切除术联合放疗治疗胸壁瘢痕疙瘩的疗效观察

Clinical outcomes of keloid core excision combined with radiotherapy in treatment of chest keloid

  • 摘要:
      背景  发生在胸壁的瘢痕疙瘩,因其局部张力大而导致瘢痕疙瘩较其他部位面积大、症状重,中、大型胸壁瘢痕疙瘩是临床治疗难点。常见的手术方式包括直接切除缝合、皮瓣转移、游离植皮等,即便配合了术后放射治疗,疗效和患者满意度仍不高。
      目的  探讨瘢痕核心切除术联合放疗治疗胸壁瘢痕疙瘩的疗效和患者满意度。
      方法  回顾性研究2016年8月- 2021年3月于解放军总医院第一医学中心整形修复科行瘢痕疙瘩核心组织切除术的胸壁瘢痕疙瘩患者,在保留1 mm厚度瘢痕皮片情况下完整剥离并切除瘢痕核心组织。患者术后均放疗3 ~ 5次。第1次放疗于术后24 h内完成,每次单剂量为3 ~ 5 Gy,总剂量范围15 ~ 20 Gy。并常规辅以外用硅凝胶、弹力衣压迫治疗;术后定期随访,若局部出现瘢痕增生,进行激素瘢痕内注射治疗。应用患者与观察者瘢痕评估量表(patient and observer scar assessment scale,POSAS)评估瘢痕疙瘩治疗前后变化,统计治疗有效率和患者满意度。
      结果  纳入23例胸壁瘢痕疙瘩患者,共30个病灶。男性10例,女性13例。中位年龄为29岁,中位病程96个月,病灶面积最小2 cm × 2 cm,最大20 cm × 7 cm;病变部位:前胸壁21处(70%),其中胸骨柄区域10处(33%),胸骨体区域6处(20%),剑突、肋弓区域3处(10%),前肋间区域2处(7%);后胸壁9处(30%),其中肩胛骨区域8处(27%),后肋间区域1处(3%)。其中8处瘢痕疙瘩伴感染灶。中位随访时间12个月,治疗后患者瘢痕评估量表评分、观察者瘢痕评估量表评分和POSAS总分均较治疗前显著降低(P均<0.05)。30处瘢痕疙瘩中,效果良好14处,有效13处,无效3处,治疗总有效率为90% (27/30)。3例(13%)患者对疗效非常满意,17例(74%)患者对疗效满意,3例(13%)患者对疗效不满意,总体满意率为87%(20/23)。
      结论  瘢痕疙瘩核心切除术联合术后电子射线放射治疗是治疗胸壁瘢痕疙瘩的一种安全、有效的方法,尤其适用于胸骨中上段中、大型瘢痕疙瘩,以及胸壁多发瘢痕疙瘩的治疗。

     

    Abstract:
      Background  Due to the high local tension, chest wall keloid tends to have a relatively large area and severe symptoms and is thus difficult to treat in clinical practice. Common surgical methods include direct resection and suture, skin flap transfer, and free skin grafting; however, due to the high local tension after surgery, there is still a lack of satisfactory treatment outcome and a low degree of satisfaction even in combination with postoperative radiotherapy.
      Objective  To investigate the clinical effect of keloid core excision combined with radiotherapy in the treatment of chest wall keloid and the degree of satisfaction of patients.
      Methods  A retrospective analysis was performed for the patients with chest wall keloid who underwent keloid core excision in our department from August 2016 to March 2021, and keloid core tissue was completely stripped and excised while the skin with a thickness of 1 mm was preserved. The patients underwent radiotherapy for 3-5 times after surgery, and the first session of radiotherapy was completed within 24 hours after surgery, with a single dose of 3-5 Gy and a total dose of 15-20 Gy. The patients were also given conventional treatment with silicone gel for external application and elastic clothing compression, and the patients with local hyperplasia were treated with glucocorticoid injection. The Patient and Observer Scar Assessment Scale (POSAS) was used to evaluate the changes of keloid after treatment, and a statistical analysis was performed for response rate and degree of satisfaction.
      Results  A total of 23 patients with 30 keloids were included in analysis, among whom there were 10 male patients and 13 female patients, with a median age of 29 years and a median course of disease of 96 months. The minimum area of lesion was 2 cm×2 cm, and the maximum area was 20 cm×7 cm. As for the location of lesion, of all 30 lesions, 21 lesions (70%) were located on the anterior chest wall, with 10 lesions (33%) on the manubrium sterni, 6 (20%) on the sternal body, 3 (10%) on the xiphoid process and costal arch and 2 (7%) in the anterior intercostal space, and the other 9 lesions (30%) were located on the posterior chest wall, with 8 (27%) on the scapula and 1 (3%) in the posterior intercostal space. Among these 30 keloids, 8 had focus of infection. The median follow-up time was 12 months. After treatment, there were significant reductions in the scores of Patient Scar Assessment Scale and Observer Scar Assessment Scale and the total of POSAS (all P <0.05). Among the 30 keloids, 14 had good response, 13 had certain response, and 3 had no response, resulting in an overall response rate of 90% (27/30). Of all 23 patients, 3 (13%) were very satisfied with the treatment outcome, 17 (74%) were satisfied, and 3 (13%) were not satisfied, with an overall satisfaction rate of 87% (20/23).
      Conclusion  Keloid core excision combined with postoperative electron beam radiation therapy is a safe and effective method for the treatment of chest wall keloid, especially for medium-sized and large keloids in the middle and upper sections of the sternum and multiple chest wall keloids.

     

/

返回文章
返回